Cost-Effectiveness of Treatment Strategies for BRAF-Mutated Metastatic Melanoma

Open Access

Peer-reviewed

Research Article

Patti Curl ,

* E-mail: patti.curl@ucsf.edu

Affiliation University of California San Francisco, San Francisco, California, United States of America
⨯
Igor Vujic,

Affiliations University of California San Francisco, San Francisco, California, United States of America, The Rudolfstiftung Hospital, Vienna, Austria
⨯
Laura J. van ‘t Veer,

Affiliation UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, California, United States of America
⨯
Susana Ortiz-Urda ,

Contributed equally to this work with: Susana Ortiz-Urda, James G. Kahn

Affiliation UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, California, United States of America
⨯
James G. Kahn

Contributed equally to this work with: Susana Ortiz-Urda, James G. Kahn

Affiliation University of California San Francisco, San Francisco, California, United States of America
⨯

Reader Comments (0)

Cancer treatment
Is the Subject Area "Cancer treatment" applicable to this article?

Thanks for your feedback.
Prognosis
Is the Subject Area "Prognosis" applicable to this article?

Thanks for your feedback.
Melanoma
Is the Subject Area "Melanoma" applicable to this article?

Thanks for your feedback.
Cost-effectiveness analysis
Is the Subject Area "Cost-effectiveness analysis" applicable to this article?

Thanks for your feedback.
Metastasis
Is the Subject Area "Metastasis" applicable to this article?

Thanks for your feedback.
Decision trees
Is the Subject Area "Decision trees" applicable to this article?

Thanks for your feedback.
Progressive diseases
Is the Subject Area "Progressive diseases" applicable to this article?

Thanks for your feedback.
Skin tumors
Is the Subject Area "Skin tumors" applicable to this article?

Thanks for your feedback.